Bruce Charles has an appointment as Reader in the School of Pharmacy. He joined the University in 1988 following 10 years as Senior Scientist in the Department of Clinical Pharmacology, Princess Alexandra Hospital and 2 years as a Harkness Fellow at the University of Iowa (USA). In recent years he has had a major role in the development of new courses in pharmacotherapeutics. He currently teaches in all years of the BPharm course.
His research encompasses many areas of human and veterinary pharmacotherapeutics, especially population modelling approaches to studying pharmacokinetics in very premature neonates and older children. An example is his recent research funded by the NHMRC which has led to caffeine being adopted as the drug of first choice in the treatment of apnoea of prematurity in Australian hospitals.